Treatment of Adult Acute Non-lymphoblastic Leukemia Using Intermittent Combination Chemotherapy with Daunomycin, Cytosine Arabinoside, 6-Mercaptopurine and Prednisolone-DCMP Two Step Therapy

Abstract

A regime of treatment of acute non-lymphoblastic leukemia in adult, employing DMCP protocol, especially two step method consisting of daunorubicin, cytosine arabinoside, 6-mercaptopurine and prednisolone is described. Out of 32 adult patients with ANLL treated with DCMP regime 26 (81.3%) achieved complete remission. The median durations of complete remission and survival were 53 weeks and 54 weeks, respectively. The longest duration of complete remission was more than 220 weeks, and 3 cases are still maintaining initial complete remission more than 3 years.